The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: Gene-environment interaction

Psychiatric Genetics

Volumn 17, Issue 6, 2007, Pages 323-332

  Vanyukov, Michael M ^a,c   Maher, Brion S ^a,b   Devlin, Bernie ^a   Kirillova, Galina P ^a   Kirisci, Levent ^a   Yu, Ling Mei ^a   Ferrell, Robert E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antisocial; Drug abuse; Monoamine oxidase A; Promoter VNTR; Suppression

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING);

ADOLESCENT; ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD PARENT RELATION; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISRUPTIVE BEHAVIOR; DNA POLYMORPHISM; DRUG ABUSE; EUROPEAN AMERICAN; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; METHODOLOGY; PERCEPTION; PRIORITY JOURNAL; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; RATING SCALE; RISK ASSESSMENT; SCHOOL CHILD; SUBSTANCE ABUSE; TANDEM REPEAT; ADDICTION; CAUCASIAN; CHILD; EMOTION; ENVIRONMENT; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; MENTAL DISEASE; NUCLEAR FAMILY; REGRESSION ANALYSIS;

ADULT; CHILD; EMOTIONS; ENVIRONMENT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MONOAMINE OXIDASE; NUCLEAR FAMILY; PARENT-CHILD RELATIONS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REGRESSION ANALYSIS; RISK ASSESSMENT; SUBSTANCE-RELATED DISORDERS;

EID: 38749120317     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32811f6691     Document Type: Article

References (54)

1. Anderson DA, Hamilton M (2005). Gender role stereotyping of parents in children's picture books: the invisible father. Sex Roles 52:145-151.
2. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E (2002). Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 110:1-7.
3. Baron RM, Kenny DA (1986). The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173-1182.
4. Baumrind D (1978). Parental disciplinary patterns and social competence in children. Youth and Society 9:239-276.
5. Baumrind D (2005). Patterns of parental authority and adolescent autonomy. New Dir Child Adolesc Dev 108:61-69.
6. Bednar DE, Fisher TD (2003). Peer referencing in adolescent decision making as a function of perceived parenting style. Adolescence 38:607-621.
7. Blair RJ (2001). Neurocognitive models of aggression, the antisocial personality disorders, and psychopathy. J Neurol Neurosurg Psychiatry 71:727-731.
8. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA (1993a). Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578-580.
9. Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, et al. (1993b). X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 52:1032-1039.
10. Burt SA, Krueger RF, McGue M, Iacono WG (2001). Sources of covariation among attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder: the importance of shared environment. J Abnorm Psychol 110:516-525.
11. Burt SA, Krueger RF, McGue M, Iacono W (2003). Parent-child conflict and the comorbidity among childhood externalizing disorders. Arch Gen Psychiatry 60:505-513.
12. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science 297:851-854.
13. Conger AJ (1974). A revised definition for suppressor variables: a guide to their identification and interpretation. Educ Psychol Measurement 34:35-46.
14. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
15. Denney RM, Koch H, Craig IW (1999). Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet 105:542-551.
16. Foley DL, Eaves LJ, Wormley B, Silberg JL, Maes HH, Kuhn J, et al. (2004). Childhood adversity, monoamine oxidase A genotype, and risk for conduct disorder. Arch Gen Psychiatry 61:738-744.
17. Gade R, Muhleman D, Blake H, MacMurray J, Johnson P, Verde R, et al. (1998). Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol Psychiatry 3:50-60.
18. Hotamisligil GS, Breakefield XO (1991). Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383-392.
19. Jacob T, Seilhamer R (1983). Adaptation of the Areas of Change Questionnaire for parent-child relationship assessment. Am J Fam Therapy 13:28-38.
20. Kendler KS, Jacobson KC, Prescott CA, Neale MC (2003). Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160:687-695.
21. Kirisci L, Dunn MG, Mezzich AC, Tarter RE (2001). Impact of parental substance use disorder and child neglect severity on substance use involvement in male offspring. Prev Sci 2:241-255.
22. Koeske GF (1998). Suppression in the study of parenting and adolescent symptoms: statistical nuisance and nonsense or scientific explanation? J Soc Service Res 24:111-130.
23. Kosten TA, Rounsaville BJ (1992). Sensitivity of psychiatric diagnosis based on the best estimate procedure. Am J Psychiatry 149:1225-1227.
24. London ED, Ernst M, Grant S, Bonson K, Weinstein A (2000). Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex 10:334-342.
25. MacKinnon DP, Krull JL, Lockwood CM (2000). Equivalence of the mediation, confounding and suppression effect. Prevention Sci 1:173-181.
26. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM (2002). Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 12:207-215.
27. Manuck SB, Flory JD, Muldoon MF, Ferrell RE (2002). Central nervous system serotonergic responsivity and aggressive disposition in men. Physiol Behav 77:705-709.
28. Merikangas KR, Risch N (2003). Genomic priorities and public health. Science 302:599-601.
29. Moffitt TE, Caspi A, Rutter M (2005). Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 62:473-481.
30. Nadder TS, Silberg JL, Eaves LJ, Maes HH, Meyer JM (1998). Genetic effects on ADHD symptomatology in 7- to 13-year-old twins: results from a telephone survey. Behav Genet 28:83-99.
31. Nilsson KW, Sjoberg RL, Damberg M, Leppert J, Ohrvik J, Alm PO, et al. (2006). Role of monoamine oxidase a genotype and psychosocial factors in male adolescent criminal activity. Biol Psychiatry 59:121-127.
32. Orvaschel H, Puig-Antich J, Chambers W, Tabrizi MA, Johnson R (1982). Retrospective assessment of prepubertal major depression with the Kiddie-SADS-e. J Am Acad Child Psychiatry 21:392-397.
33. Passamonti L, Fera F, Magariello A, Cerasa A, Gioia MC, Muglia M, et al. (2006). Monoamine oxidase-A genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry 59:334-340.
34. Sabol SZ, Hu S, Hamer D (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
35. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, et al. (1999). A genetic association for cigarette smoking behavior. Health Psychol 18:7-13.
36. Saito T, Lachman HM, Diaz L, Hallikainen T, Kauhanen J, Salonen JT, et al. (2002). Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res 109:113-119.
37. Samochowiec J, Lesch KP, Rottmann M, Smolka M, Syagailo YV, Okladnova O, et al. (1999). Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res 86:67-72.
38. Schaefer E (1965). Children's reports of parental behavior: an inventory. Child Development 36:417-424.
39. Silberg J, Rutter M, Meyer J, Maes H, Hewitt J, Simonoff E, et al. (1996). Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. J Child Psychol Psychiatry 37:803-816.
40. Steinberg L, Lamborn SD, Darling N, Mounts NS, Dornbusch SM (1994). Overtime changes in adjustment and competence among adolescents from authoritative, authoritarian, indulgent, and neglectful families. Child Devel 65:754-770.
41. Spitzer RL, Williams JB, Gibbon M (1987). Instruction manual for the Structured Clinical Interview for DSM-III-R. New York: Biometrics Research Department, New York State Psychiatric Institute.
42. Sullivan PF, Kendler KS, Neale MC (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187-1192.
43. Tarter R, Vanyukov M, Giancola P, Dawes M, Blackson T, Mezzich A, et al. (1999). Etiology of early age onset substance use disorder: a maturational perspective. Dev Psychopathol 11:657-683.
44. Tarter RE, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M, et al. (2003). Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 160:1078-1085.
45. Tarter RE, Vanyukov MM (2001). Theoretical and operational framework for research into the etiology of substance use disorders. J Child Adolesc Subst Abuse 10:1-12.
46. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, et al. (1998). Co-occurrence of abuse of different drugs in men: the role of drug- specific and shared vulnerabilities. Arch Gen Psychiatry 55:967-972.
47. Vanyukov MM, Kirisci L, Tarter RE, Simkevitz HF, Kirillova GP, Maher BS, Clark DB (2003a). Liability to substance use disorders: 2. A measurement approach. Neurosci Biobehav Rev 27:517-526.
48. Vanyukov MM, Moss HB, Yu LM, Deka R (1995a). A dinucleotide repeat polymorphism at the gene for monoamine oxidase A and measures of aggressiveness. Psychiatry Res 59:35-41.
49. Vanyukov MM, Moss HB, Yu LM, Tarter RE, Deka R (1995b). Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. Am J Med Genet 60:122-126.
50. Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB (2003b). Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci Biobehav Rev 27:507-515.
51. Vanyukov MM, Maher BS, Devlin B, Tarter RE, Kirillova GP, Yu LM, et al. (2004). Haplotypes of the monoamine oxidase genes and the risk for substance use disorders. Am J Med Genet B Neuropsychiatr Genet 125B:120-125.
52. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, et al. (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015-2021.
53. Young SE, Stallings MC, Corley RP, Krauter KS, Hewitt JK (2000). Genetic and environmental influences on behavioral disinhibition. Am J Med Genet 96:684-695.
54. Zalsman G, Huang YY, Harkavy-Friedman JM, Oquendo MA, Ellis SP, Mann JJ (2005). Relationship of MAO-A promoter (u-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 132:100-103.